Mobile Investor

 Stock Information
JNJ (NYSE)
Last Price: 86.82
Last Trade: 4:03 PM ET - May 24, 2013
Change: 0.39 down  (0.45%)
Open: 86.80
Close: 87.21
High: 87.03
Low: 86.49
52-Week High: 89.99
52-Week Low: 61.71
Volume: 10,290,600
Stock price graph
 Recent News
May 23, 2013
Johnson & Johnson Pharmaceuticals Segment Poised to Continue Driving Growth with More than 10 Potential New Product Filings by 2017
May 21, 2013
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
May 20, 2013
Janssen Oncology Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting, Including ZYTIGA®, Ibrutinib and Daratumumab Data
May 15, 2013
SIMPONI® (Golimumab) Receives FDA Approval For Ulcerative Colitis
May 13, 2013
Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL® SMARTTOUCH™ Catheter
 Events & Presentations
May 23, 2013 - 8:30 AM ET
Johnson & Johnson Pharmaceuticals Business Review
May 3, 2013 - 8:30 AM ET
Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
 Financial Filings
May 3, 2013
Form 10-Q - Johnson & Johnson
Mar 13, 2013
Form DEF 14A - Johnson & Johnson
Feb 22, 2013
Form 10-K - Johnson & Johnson
Nov 9, 2012
Form 10-Q - Johnson & Johnson
Aug 2, 2012
Form 10-Q - Johnson & Johnson
May 7, 2012
Form 10-Q - Johnson & Johnson
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2013 Johnson & Johnson